相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。撤稿声明: Adjuvant radiotherapy in patients with diffuse large B-cell lymphoma in advanced stage (III/IV) improves the outcome in the rituximab era (Retraction of Vol 24, Pg 507, 2019)
Agustin Aviles et al.
HEMATOLOGY (2019)
The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy
Tarec Christoffer El-Galaly et al.
EUROPEAN JOURNAL OF CANCER (2017)
International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)
A. Younes et al.
ANNALS OF ONCOLOGY (2017)
Influence of dose reduction of vincristine in R-CHOP on outcomes of diffuse large B cell lymphoma
Yoshikazu Utsu et al.
ANNALS OF HEMATOLOGY (2016)
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
Norbert Schmitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK's Haematological Malignancy Research Network
A. Smith et al.
BRITISH JOURNAL OF CANCER (2015)
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
Thomas J. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
V. A. Carozzi et al.
NEUROSCIENCE LETTERS (2015)
Differential Impact of Relative Dose-Intensity Reductions in Diffuse Large B-Cell Lymphoma Treated with R-CHOP21 or R-CHOP14
Antonio Gutierrez et al.
PLOS ONE (2015)
Retrospective Analysis of Relative Dose Intensity in Patients With Non-Hodgkin Lymphoma Receiving CHOP-based Chemotherapy and Pegfilgrastim
Lodovico Balducci et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2014)
Pharmacokinetic evaluation of vincristine for the treatment of lymphoid malignancies
Rabih Said et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2014)
Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma
Gerhard Held et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab
W. M. Tai et al.
ANNALS OF HEMATOLOGY (2011)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
Elias Campo et al.
BLOOD (2011)
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2011)
Importance of Relative Dose Intensity in Chemotherapy for Diffuse Large B-Cell Lymphoma
Hiroki Yamaguchi et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2011)
Importance of maintaining the relative dose intensity of CHOP-like regimens combined with rituximab in patients with diffuse large B-cell lymphoma
Tsuneaki Hirakawa et al.
ANNALS OF HEMATOLOGY (2010)
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
D. Villa et al.
ANNALS OF ONCOLOGY (2010)
Impact of relative dose intensity (RDI) in CHOP combined with rituximab (R-CHOP) on survival in diffuse large B-cell lymphoma
Yoshiki Terada et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
V. Boehme et al.
ANNALS OF ONCOLOGY (2007)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
分享论文
